HCA Healthcare, Inc. $HCA Shares Sold by Trivium Point Advisory LLC

Trivium Point Advisory LLC lowered its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 11.9% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 7,877 shares of the company’s stock after selling 1,059 shares during the period. Trivium Point Advisory LLC’s holdings in HCA Healthcare were worth $3,357,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Norges Bank acquired a new position in HCA Healthcare in the 2nd quarter worth $1,152,408,000. Viking Global Investors LP lifted its stake in shares of HCA Healthcare by 58.5% in the second quarter. Viking Global Investors LP now owns 1,872,133 shares of the company’s stock worth $717,214,000 after acquiring an additional 690,773 shares in the last quarter. Nordea Investment Management AB grew its stake in HCA Healthcare by 5.2% during the 3rd quarter. Nordea Investment Management AB now owns 975,741 shares of the company’s stock valued at $415,656,000 after purchasing an additional 47,960 shares in the last quarter. Pacer Advisors Inc. raised its position in shares of HCA Healthcare by 6,115.3% in the 3rd quarter. Pacer Advisors Inc. now owns 911,096 shares of the company’s stock valued at $388,309,000 after purchasing an additional 896,437 shares in the last quarter. Finally, LSV Asset Management grew its position in shares of HCA Healthcare by 0.4% during the second quarter. LSV Asset Management now owns 868,849 shares of the company’s stock worth $332,856,000 after buying an additional 3,396 shares in the last quarter. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Analysts Set New Price Targets

Several brokerages have weighed in on HCA. UBS Group raised their price objective on shares of HCA Healthcare from $598.00 to $635.00 and gave the stock a “buy” rating in a report on Monday. Truist Financial lifted their price target on HCA Healthcare from $520.00 to $546.00 and gave the stock a “buy” rating in a research note on Wednesday, January 28th. Royal Bank Of Canada increased their target price on HCA Healthcare from $525.00 to $555.00 and gave the stock an “outperform” rating in a report on Wednesday, January 28th. Robert W. Baird raised their price objective on HCA Healthcare from $423.00 to $450.00 and gave the stock a “neutral” rating in a research note on Thursday, December 11th. Finally, Wall Street Zen cut shares of HCA Healthcare from a “strong-buy” rating to a “buy” rating in a report on Saturday, February 14th. Sixteen analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $534.50.

Insider Activity at HCA Healthcare

In other HCA Healthcare news, SVP Christopher F. Wyatt sold 4,000 shares of the firm’s stock in a transaction dated Wednesday, February 11th. The shares were sold at an average price of $505.00, for a total transaction of $2,020,000.00. Following the transaction, the senior vice president owned 44,379 shares of the company’s stock, valued at approximately $22,411,395. This trade represents a 8.27% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Michael S. Cuffe sold 1,500 shares of the business’s stock in a transaction on Tuesday, February 3rd. The stock was sold at an average price of $498.09, for a total value of $747,135.00. Following the completion of the sale, the executive vice president directly owned 30,003 shares in the company, valued at $14,944,194.27. This represents a 4.76% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 15,214 shares of company stock worth $7,797,595 in the last 90 days. Corporate insiders own 1.30% of the company’s stock.

HCA Healthcare Price Performance

Shares of NYSE HCA opened at $528.69 on Friday. HCA Healthcare, Inc. has a 1-year low of $295.00 and a 1-year high of $552.90. The firm has a market capitalization of $118.23 billion, a PE ratio of 18.63, a P/E/G ratio of 1.62 and a beta of 1.36. The business’s fifty day moving average price is $493.99 and its two-hundred day moving average price is $459.94.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings data on Tuesday, January 27th. The company reported $8.01 earnings per share for the quarter, topping analysts’ consensus estimates of $7.37 by $0.64. HCA Healthcare had a net margin of 8.97% and a negative return on equity of 409.11%. The business had revenue of $19.51 billion for the quarter, compared to analysts’ expectations of $19.67 billion. During the same quarter last year, the company earned $6.22 EPS. The company’s revenue for the quarter was up 6.7% compared to the same quarter last year. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Equities research analysts expect that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 31st. Investors of record on Tuesday, March 17th will be paid a dividend of $0.78 per share. This is an increase from HCA Healthcare’s previous quarterly dividend of $0.72. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date is Tuesday, March 17th. HCA Healthcare’s dividend payout ratio (DPR) is presently 10.15%.

HCA Healthcare News Summary

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: Analyst upgrade/price-target lift — Mizuho set a new $585 price target for HCA, reinforcing bullish analyst sentiment and helping support the stock’s rally. Read More.
• Positive Sentiment: Post‑earnings momentum — Analysts and writeups (Zacks) highlight HCA’s strong post‑earnings performance (EPS beat and raised FY26 guidance), which is a key reason for recent share gains. Read More.
• Positive Sentiment: Investor roadshow / conference calendar — HCA will present at multiple March healthcare conferences (TD Cowen, Raymond James, Barclays, Leerink, Oppenheimer), increasing institutional visibility and liquidity. Read More.
• Positive Sentiment: Expansion & facility investments — TriStar (an HCA division) is planning a $21M freestanding ER in Fairview and HCA (with Ascension) is targeting high‑growth markets with ER builds, signaling organic growth and franchise expansion. Read More.
• Positive Sentiment: Market strategy: ER build partnership — Coverage on HCA and Ascension targeting growth markets with ER builds points to disciplined capital deployment to capture patient volumes. Read More.
• Positive Sentiment: Quality recognition — A local report highlights high marks for HCA on CABG outcomes, which supports reputation and could help referrals/volume over time. Read More.
• Positive Sentiment: Brand and reputation wins — HCA and several systems made Fortune’s Most‑Admired list, a positive for reputation and hiring/partnerships. Read More.
• Neutral Sentiment: Local market developments — Coverage of Northeast Florida health‑care development (HCA, Baptist, Ascension St. Vincent’s) outlines competitive dynamics; useful for regional growth outlook but not an immediate system‑wide catalyst. Read More.
• Neutral Sentiment: New clinic opening — HCA Florida’s North Florida Hospital launched a test‑and‑treat clinic (local operational expansion), positive for access but a limited impact on consolidated results. Read More.
• Neutral Sentiment: Governance / compensation update — HCA disclosed its 2026 executive bonus plan and a longtime board member will retire; watch for details tying pay to metrics, but this is mostly governance housekeeping. Read More.
• Neutral Sentiment: Comparative performance pieces — A Yahoo Finance comparison of HCA vs. peer healthcare stocks offers context for investors but contains no new company-specific catalyst. Read More.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.